Clinical Trial Update: CAR T Cell Immunotherapy for Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of CAR T cell immunotherapy for pancreatic cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CAR T cell immunotherapy (pancreatic cancer) (Chimeric antigen receptor T cell therapy)

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Cancer, Cancer of the Pancreas | Phase 1 | Status: TERMINATED